Inmaculada G. R.
- Country
- Spain
- Department
- Cardiologia pediatrica - Patient Visits
Research Overview
- A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study with Open-Label Extension Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged ≥2 to <18 years with Pulmonary Arterial Hypertension
- (21466) A multicenter, randomized, double-blind, placebo-controlled, Phase 3 study to investigate the efficacy, safety, and PK/ PD of finerenone, in addition to standard-of-care, in pediatric patients, 6 months to < 18 years of age, with heart failure (HF) and left ventricular systolic dysfunction (LVSD)
- (21467) A Phase 3, single-arm, open-label extension study to evaluate the safety of finerenone in addition to standard of care, in pediatric heart failure patients, from birth to 18 years of age, with left ventricular systolic dysfunction (LVSD)
Data & Insights
Has run more than one trial at 43 of 64 partner sites.
Specializations
Pediatric Cardiology
Clinical research activity is centered in pediatric cardiology, with interest in cardiovascular conditions that affect children and young patients. The trial portfolio also extends to inherited and structural heart disease, rhythm disorders, and heart failure-related care.
- Congenital cardiomyopathy
- Atrial fibrillation
- Heart failure
- Hypertrophic cardiomyopathy
Work at Virgen del Rocío University Hospital reflects involvement in cardiovascular innovation across prevention, disease modification, and long-term management.
Pediatric and Young Adult Hematology
Research involvement includes acute lymphoblastic leukemia, acute myeloid leukemia, and other hematologic malignancies, with attention to treatment-resistant and relapsed disease. The portfolio also includes inherited bleeding disorders and marrow failure-related conditions.
- Acute lymphoblastic leukemia
- Acute myeloid leukemia
- Diffuse large B-cell lymphoma
- Hemophilia
These activities align with therapeutic development in cellular therapy, immunotherapy, and precision hematology.
Oncology
The investigator is involved in a broad oncology landscape spanning breast cancer, lung cancer, gastrointestinal malignancies, and urothelial carcinoma. Research interests also include advanced solid tumors, metastatic disease, and biomarker-defined cancer populations.
- Breast cancer
- Non-small cell lung cancer
- Colorectal cancer
- Urothelial carcinoma
Therapeutic focus includes targeted oncology, immune-based treatment strategies, and approaches for advanced and metastatic disease.
Pediatric and Immune-Mediated Disorders
Clinical research also covers pediatric immune-mediated disease, including inflammatory and autoimmune conditions such as juvenile idiopathic arthritis, systemic lupus erythematosus, and Crohn’s disease. Respiratory and allergic disorders are also represented.
- Juvenile idiopathic arthritis
- Systemic lupus erythematosus
- Crohn’s disease
- Asthma
This area includes interest in immune modulation, chronic inflammation, and disease control in pediatric care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.